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Intake of non-nutritive sweeteners is
associated with an unhealthy lifestyle: a
cross-sectional study in subjects with
morbid obesity
Robert Winther1,2, Martin Aasbrenn3,4 and Per G. Farup1,4*
Abstract
Background: Subjects with morbid obesity commonly use Non-Nutritive Sweeteners (NNS), but the health-related
effects of NNS have been questioned. The objectives of this study were to explore the associations between theuse
of NNS and the health and lifestyle in subjects with morbid obesity.
Methods: This cross-sectional study included subjects with morbid obesity (BMI ≥ 40 kg/m2 or ≥35 kg/m2 with
obesity-related comorbidity). Information about demographics, physical and mental health, and dietary habits was
collected, and a blood screen was taken. One unit of NNS was defined as 100 ml beverages with NNS or 2 tablets/
units of NNS for coffee or tea. The associations between the intake of NNS and the health-related variables were
analyzed with ordinal regression analyses adjusted for age, gender and BMI.
Results: One hundred subjects (women/men 83/17; mean age 44.3 years (SD 8.5)) were included. Median intake of
NNS was 3.3 units (range 0 – 43). Intake of NNS was not associated with BMI (p = 0.64). The intake of NNS was
associated with reduced heavy physical activity (p = 0.011), fatigue (p < 0.001), diarrhea (p = 0.009) and reduced
well-being (p = 0.046); with increased intake of total energy (p = 0.003), fat (p = 0.013), carbohydrates (p = 0.002),
sugar (p = 0.003) and salt (p = 0.001); and with reduced intake of the vitamins A (p = 0.001), C (p = 0.002) and D
(p = 0.016).
Conclusions: The use of NNS-containing beverages was associated with an unhealthy lifestyle, reduced physical
and mental health and unfavourable dietary habits with increased energy intake including sugar, and reduced
intake of some vitamins.
Keywords: Diet, General health, Life style, Non-nutritive sweeteners, Obesity
Background
In adults, the global prevalence rates of overweight and
obesity, defined as Body Mass Index (BMI) above 25 and
30 kg/m2, were in 2014 39% and 13% respectively [1]. The
prevalence rates have more than doubled since 1980 and
the disorders have been mentioned as one of the largest
public health concerns worldwide because of the increased
risk of serious non-communicable diseases such as cancer,
cardiovascular diseases, and diabetes [1–3]. In Norway, 1
in 4 middle-aged men and 1 in 5 women have a BMI above
30 kg/m2 [4].
The “obesity epidemic” (the rapidly increasing preva-
lence) is caused by environmental and societal changes
with increased intake of energy-dense food and
increased physical inactivity [1]. Interventions at the so-
cietal level should facilitate regular physical activity and
make healthier dietary choices available [1]. At the indi-
vidual level, it is recommended to limit the energy intake
from fat and sugar, to increase the intake of fruits,
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vegetables, legumes, whole grains and nuts, and to in-
crease the regular physical activity [1].
To maintain the pleasure of the sweet taste and at the
same time reduce the energy intake, subjects with obes-
ity commonly replace sugar by non-nutritive sweeteners
(NNS). The reasoning is logical and the producers of
NNS have promoted the use and raised the global mar-
ket to $ 5.5 billion in 2014 [5]. The effect of NNS on
weight prevention and reduction is controversial, and
serious safety concerns have been raised [6–11]. The
controversies are in part related to the study design.
Observational studies indicate weight gain and interven-
tional studies the opposite [12]. Both designs are prone
to bias. Bias is also introduced by the industry; the rela-
tive risk to have favourable results in industry-sponsored
reviews was 17.25 (95%CI 2.34 to 127.29) times that of
industry independent ones [2]. Most studies have fo-
cused on the effect on body weight, whereas associations
with lifestyle and general health have been less studied.
The aims of this study in subjects with morbid obesity
were to assess associations between the use of NNS and
demographics, lifestyle, physical and mental health, diet-
ary habits, comorbidity and a blood screen.
Methods
Study design
This cross-sectional study was performed at the unit for
morbid obesity at Innlandet Hospital Trust, Gjøvik,
Norway. Consecutive subjects were included from
December 2012 through September 2014. A medical his-
tory was taken, a physical examination was performed,
and a blood sample was collected for further analyses.
The patients filled in paper-based questionnaires. A
trained study nurse was responsible for the care of the
patients and the practical work.
Subjects
Consecutive subjects aged 18 – 65 years old with a
BMI ≥ 40 kg/m2 or ≥35 kg/m2 with obesity-related com-
plications referred for evaluation of bariatric surgery or
conservative treatment were included in a comprehen-
sive study. Subjects with serious somatic and psychiatric
disorders judged as unrelated to obesity and subjects
with previous major surgery including bariatric surgery
were excluded. Only subjects with satisfactorily filled in
food frequency questionnaires (FFQ) were included in
this study.
Variables
Demographics: Gender; age (years); body weight (kg),
height (meter), body mass index (BMI, kg/m2); cohabit-
ant (yes/no); working (no / part-time / full-time); smok-
ing (never / previously / daily); and overall physical
activity (score 0 – 8) and heavy physical activity (hours
per week: no / <1 / 1-2 / >2).
Diseases, disorders and well-being: Perceived state of
health (poor / not quite good / good / very good); present
or previous somatic disorders including hypertension, dia-
betes, and fibromyalgia (yes / no); muscle-skeletal pain
score (score 0-12); WHO-5 well-being index (score 0-100;
score ≤ 28 = likely depression; score ≤ 50 = low mood);
Hopkins Symptom Checklist −10 (HSCL-10) for measure-
ment of mental distress (score 1-4; mental distress ≥1,85);
Fatigue severity scale (FSS; score 9-63, score ≥ 36 = fatigue)
[13–15]. The functional gastrointestinal disorders Irritable
bowel Syndrome (IBS), functional constipation, functional
diarrhea, and functional bloating were diagnosed with a
validated Norwegian translation of the Rome III criteria;
and the degree of gastrointestinal complaints with Gastro-
intestinal Symptom Rating Scale – IBS (GSRS-IBS) with
subscales for GSRS-diarrhea, −constipation and -bloating
(scores 1-7) [16, 17].
The dietary intake of nutrients, energy, and NNS was
assessed with an FFQ prepared and validated by the De-
partment of Nutrition at the University of Oslo, Norway
who also analyzed the FFQs with their in-house calcula-
tion program (KBS, version 7.3, food database AE-14)
based on the official Norwegian food composition table
from 2016 (http://www.matvaretabellen.no). The fre-
quency was reported as less than once/week; 1-2 times/
week; 3-4 times/week; 5-6 times/week; once daily; 2
times/day; 3 times/day; ≥ 4 times/day. The portion size
was reported in liter (1/5, 1/3: 1/2, 1) and/or glasses and
the amounts converted into gram/day. As the FFQ did
not capture the type or amount of NNS used in bever-
ages or NNS tablets, the calculation of the NNS intake
was performed pragmatically. One unit of NNS was
defined as 100 ml NNS-containing beverage (divided
into carbonated and non-carbonated beverage). This was
considered as the amount of NNS that would equal the
sweetening of regular sugar containing beverages with
10% of sugar (10 g/100 ml). One tablet of NNS was
approximately equal to 1 teaspoon of sugar (5 g). Thus,
2 NNS tablets/units for use in tea or coffee were judged
as equally amount of 100 ml NNS in beverages. 100 ml
was chosen as the unit because the subjects reported the
intake in liter and/or glasses and the unit is easy to
understand. Intakes of NNS from other sources than
beverages and tablets used in beverages were not in-
cluded in the FFQ. Sugar alcohols and naturally-derived
sweeteners not defined as NNS were not included. A
range of hematological and biochemical blood tests in-
cluding vitamins and minerals were analyzed.
Statistics
The results have been reported as mean (SD), median
(range), and number (proportion in percentage). Because
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the intake of NNS varied markedly and was clustered in
groups, the intake was ordered in groups with roughly
uniform intake and analyzed with ordinal regression
analyses. Associations between NNS and the subjects’
characteristics and blood tests were analyzed with
ordinal logistic regression analyses adjusted for age, gen-
der and BMI and reported as B- and p-values. The asso-
ciations between NNS and dietary intake were not linear
and were analyzed with Spearman’s correlation test
reported as rho, and the p-values were calculated with
ordinal logistic fractional polynomial regression adjusted
for gender, age and BMI. The analyses were performed
with IBM SPSS Statistics for Windows, Version 24.0.
Armonk, NY: IBM Corp, and the fractional polynomial
regression analyses with STATA v14, StatCorp LLC,
Texas, USA. P-values <0.05 were judged as statistically
significant.
Ethics
The study was approved by the Norwegian Regional
Committees for Medical and Health Research Ethics, PB
1130, Blindern, 0318 Oslo, Norway (reference number
2012/966) and performed in accordance with the Declar-
ation of Helsinki. Written informed consent to partici-
pate was given by all participants before inclusion.
Results
Out of 350 consecutive subjects visiting the obesity unit,
100 (83 women and 17 men with a mean age of
44.3 years (SD 8.5)) were included in the study. The rea-
sons for the exclusion of 250 subjects are given in Fig. 1.
Table 1 gives the participants’ characteristics in detail
and the results of the blood tests. Table 2 gives the daily
dietary intake of energy, energy-yielding nutrients, NNS,
vitamins, and salt. The total intake of NNS varied from
zero to 43 units per day. High intake of NNS was associ-
ated with diabetes, reduced physical activity, fatigue,
reduced well-being, and diarrhea (Table 3). Table 4 gives
all the associations between intake of NNS and the diet-
ary intake of energy, energy-yielding nutrients, vitamins,
and salt. Intake of NNS was associated with increased
intake of energy and salt, and reduced intake of vita-
mins. The positive associations between the intake of
NNS and energy and salt were most pronounced for the
use of NNS in carbonated beverages and are presented
in Fig. 2.
Discussion
The study confirms the findings from studies in the gen-
eral population that the use of NNS is high in overweight
and obese adults [18–21]. Half of the subjects used more
than 3.3 units of NNS per day, which corresponds to
330 ml beverages with NNS. An intake of 2 – 4 l was not
uncommon.
The main finding was the associations between NNS
and an unhealthy lifestyle. In literature, less is known
about these clinically relevant outcomes than about the
weight. In this study, NNS was associated with a less
healthy diet, reduced physical activity, low well-being
and fatigue, which indicate an unhealthy lifestyle. The
results indicate that the intake of NNS-containing bever-
ages was approximately 100 ml higher in subjects with
diabetes than in those without, and the same difference
was seen between those with strong physical activity less
than 1 hour/week compared to those with more than 2
h, and in subjects with low mood. The clinical signifi-
cance of these effects are uncertain, but is indicative of
an unhealthy lifestyle associated with the use of NNS.
A high intake of NNS was associated with increased
intake of fat, proteins, carbohydrates including sugar,
Fig. 1 A flow chart of the subjects in the study
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and salt; and reduced intake of some vitamins. The high
intake of energy is harmful to obese subjects. The associ-
ation with the intake of sugar could support the hypoth-
esis that NNS encourage sugar craving and dependence
by an altered metabolism and processing of sweet taste
in the brain [22, 23]. Most of the unfavorable associa-
tions were related to the use of NNS in carbonated bev-
erages, probably because the highest intake of NNS was
from carbonated beverages. The stongest correlations
were between intake of NNS containing beverages and
salt. It is likely that these users combine the beverages
with intake of salted food and snacks, which has also
been shown by others [18]. Most of the associations be-
tween intake of NNS and energy and nutrients were
weak (rho <0.2) and NNS explain only a minor part of
the variation. The negative associations between intake
of NNS and c-peptid, HbA1c and perhaps also Hb might
have been confounded by diabetes. To adjust the ana-
lyses for all comorbidity including diabetes, in addition
to age, gender and BMI was judged as inappropriate.
The users of NNS in non-carbonated beverages, tea, and
coffee seem to have a more conscious and correct use of
NNS with a slightly reduced intake of total energy,
Table 1 The characteristics of the participants in the study
Participants’ characteristics








Gender (female/male) 83 / 17 83% / 17%
Age (years) 44.3 8.5
Body weight (kg) 121.8 16.2
BMI (kg/m2) 41.9 3.5
Living with someone (99) 84 85%
Working (no / part time / full-time) (98) 23 / 32 /
43
23%/33%/44%
Smoking (never/previously/daily) 43 /44 /
13
43%/44%/13%
Total physical activity (score 0-8) 4.6 2.2













Muscle-skeletal pain score (range 0-12) 4.0 0 – 12
Hypertension (96) 57 59%
Diabetes 20 20%
HSCL10 > 1.85 (mental distress) 27 27%
WHO-5 (low mood) (cut-off <50) 30 30%
Fatigue (cut-of >36) (99) 48 48%
Irritable bowel syndrome (97) 27 28%
Functional bloating (96) 14 15%
Functional diarrhea (97) 2 2%
GSRS-diarrhea (score 1 - 7) (80) 1.5 1.0 – 4.8
GSRS-bloating (score 1 - 7) (80) 2.3 1.0 – 6.0
Blood tests
Haemoglobin (F: 11-15; M: 13-17 g/dl) (98) 14.4 1.1
Serum iron (9-34 μmol/L (98) 15.0 5.5
Transferrin saturation (0.10-0.57) (97) 0.23 0.09
Ferritin (10-380 μg/dL) (98) 96 7 - 584
CRP (<5 mg/L) (98) 5 0 - 28
s-Glucose (4.2-6.3 mmol/L) (98) 5.7 4.0 – 23.2
HbA1C (4.3-5.6%) (98) 5.4 4.6 – 11.5
C-peptide (0.3-2.4 nmol/L) (98) 1.47 0.53 – 4.31
Cholesterol (3-7 mmol/L) (98) 5.0 1.0
HDL (F: 1.0-2.7; M: 0.8-2.1 mmol/L) (98) 1.2 0.3
LDL (1-5 mmol/L) (98) 3.3 0.9
Vitamin A (1.2-3.4 μmol/L) (91) 2.0 0.4
Vitamin B1 (122-223 nmol/l) (97) 158 27
Vitamin B6 (27-273 nmol/l) (96) 23 6 - 209
Vitamin B12 (141-700 pmol/L) (98) 338 173 - 1401
Vitamin D (45-161 nmol/L) (98) 58 23
Folic acid (9-36 nmol/l) 17 7 – 46
HSCL10 Hopkins Symptom Checklist 10, WHO-5 WHO-5 Well-Being Index,
GSRS Gastrointestinal Symptom Rating Scale, HDL High Density Lipoprotein,
LDL Low Density Lipoprotein
Table 2 Daily intake of total energy, energy-yielding nutrients,
non-nutritive sweeteners, vitamins and salt
Daily dietary intake Median Range
Energy
Total energy (kJ) 9737 2648 - 21,816
Protein (g) 109 40 - 212
Fat (g) 90 21 - 283
Carbohydrates (g) 251 65 - 903
Sugar (g) 26 1 - 632
Non-nutritive sweeteners (NNS) (unita)
NNS total 3.3 0.0 – 43.0
NNS carbonated beverages 0.4 0.0 – 40.0
NNS non-carbonated beverages 0.1 0.0 – 32.0
NNS sweeteners in coffee and tea 0.0 0.0 – 27.0
Vitamins and salt
Vitamin A (μg) 1341 352 - 4460
Vitamin B1 (mg) 2.6 0.8 – 7.8
Vitamin B2 (mg) 3.0 1.1 – 8.8
Vitamin B6 (mg) 2.7 0.9 – 10.0
Vitamin B12 (μg) 9.3 3.0 – 33.7
Vitamin C (mg) 170 11 - 623
Vitamin D (μg) 12.5 2.2 – 44.6
Folic acid (μg) 391 131 – 1077
β-carotene (μg) 4947 340 – 24,306
Salt (g) 7.5 2.4 – 18.8
a NNS One unit = 100 ml beverages with NNS or 2 units of NNS for coffee/ tea
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B p-value B p-value B p-value B p-value
Gender (female/male) −0.10 0.838 0.519 0.285 −0.049 0.924 −2.896 0.005
Age (years) −0.04 0.073 −0.014 0.544 −0.045 0.063 0.002 0.951
BMI (kg/m2) −0.025 0.640 −0.007 0.902 −0.032 0.582 0.040 0.510
Living with someone −0.728 0.151 −0.030 0.953 −0.981 0.060 −0.011 0.985
Working −0.124 0.594 0.383 0.114 −0.379 0.126 −0.047 0.858
Smoking 0.194 0.485 0.196 0.492 −0.043 0.884 −0.110 0.715
Perceived general health 0.011 0.965 0.070 0.793 0.098 0.722 0.083 0.771
Total physical activity −0.184 0.029 −0.086 0.308 −0.030 0.732 0.014 0.883
Heavy physical activity −0.477 0.011 −0.368 0.052 −0.212 0.278 0.116 0.576
Hypertension 0.201 0.607 0.261 0.518 −0.128 0.759 −0.340 0.442
Diabetes 0.971 0.039 0.639 0.174 1.227 0.012 0.171 0.748
Fibromyalgia 0.696 0.131 0.202 0.664 0.718 0.132 0.568 0.249
Muscle-skeletal pain score (range 0-12) −0.004 0.952 0.001 0.987 −0.097 0.149 0.058 0.397
HSCL10 > 1.85 0.073 0.855 −0.194 0.639 −0.664 0.137 −0.028 0.951
WHO-5 (poor wellbeing) 0.452 0.249 0.805 0.046 −0.135 0.746 −0.297 0.509
Fatigue 1.232 0.001 0.490 0.184 0.316 0.408 0.575 0.159
IBS 0.317 0.444 −0.193 0.651 0.207 0.633 −0.047 0.915
Functional bloating −0.379 0.486 0.600 0.280 −0.714 0.258 −1.365 0.067
Functional diarrhea NA NA NA NA NA NA NA NA
GSRS-diarrhea (score) 0.625 0.009 0.178 0.447 0.176 0.467 0.626 0.012
GSRS-bloating (score) −0.112 0.509 −0.033 0.849 −0.324 0.084 −0.184 0.320
Blood tests
Haemoglobin (g/dl) −0.299 0.149 −0.063 0.765 −0.625 0.007 −0.534 0.022
Serum iron (μmol/L −0.015 0.648 −0.042 0.237 −0.011 0.768 −0.049 0.205
Transferrin saturation −0.875 0.673 −0.025 0.255 −0.011 0.631 −0.033 0.167
Ferritin (μg/dL) 0.002 0.311 −0.001 0.450 0.000 0.909 −0.001 0.615
CRP (mg/L) 0.040 0.226 0.029 0.393 0.081 0.020 0.042 0.228
s-Glucose (mmol/L) 0.110 0.082 0.122 0.055 0.044 0.492 0.005 0.944
HbA1C (%) 0.294 0.052 0.235 0.117 0.367 0.018 0.076 0.644
c-peptide (nmol/L) 0.662 0.005 0.410 0.077 0.279 0.244 0.509 0.052
Cholesterol (mmol/L) 0.116 0.542 0.188 0.339 −0.043 0.830 −0.096 0.661
HDL (mmol/L) −0.612 0.291 −0.164 0.782 −1.017 0.115 0.541 0.394
LDL (mmol/L) 0.164 0.427 0.164 0.438 −0.026 0.907 −0.179 0.457
Vitamin A (μmol/L) 0.291 0.536 −0.725 0.136 −0.232 0.644 0.050 0.921
Vitamin B1 (nmol/L) 0.008 0.243 0.006 0.356 0.001 0.876 0.007 0.363
Vitamin B6 (nmol/L) 0.004 0.479 0.005 0.407 −0.011 0.178 −0.002 0.759
Vitamin B12 (pmol/L) −0.001 0.384 0.000 0.727 0.000 0.940 −0.001 0.503
Vitamin D (nmol/L) 0.006 0.458 0.012 0.166 0.001 0.952 0.000 0.966
Folic acid (nmol/L) −0.024 0.269 −0.007 0.759 −0.021 0.362 −0.018 0.433
HSCL10 Hopkins Symptom Checklist 10, WHO-5 WHO-5 Well-Being Index, IBS Irritable bowel syndrome, GSRS Gastrointestinal Symptom Rating Scale, HDL High
Density Lipoprotein, LDL Low Density Lipoprotein
The analyses have been performed with ordinal logistic regression analyses adjusted for gender, age and BMI)
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carbohydrates, and sugar. They also reduced the intake
of β-Carotene and vitamin C, indicating that they re-
duced all kinds of food including the healthy fruits and
vegetables. Opposed to the findings in this study,
population-based studies in the UK, US and Canada sug-
gest a higher dietary quality in NNS consumers than in
nonconsumers [19, 20]. The way NNS are used and the
physiological and psychological effect of NNS might dif-
fer between subjects randomly selected from the
population and subjects referred for treatment of morbid
obesity at a spesialised hospital unit. Although NNS have
been accused of a diabetogenic effect, the associations
between NNS and diabetes and c-peptide in this study
are probably explained by the higher use of NNS by sub-
jects with diabetes [24, 25].
Reduced physical and mental health was also associ-
ated with NNS. The users of NNS had a feeling of poor
well-being and more fatigue, and were less physically
Table 4 Associations between the intake of NNS and intake of energy, energy-yielding nutrients, vitamins and salt
Diet NNS Total NNS Carbonated NNS Non-carb NNS Sweeteners
rho p-value rho p-value rho p-value rho p-value
Total energy (kcal) 0.138 0.003 0.235 0.004 - 0.101 0.0329 0.014 0.080
Protein (g) 0.081 0.106 0.198 0.012 - 0.066 0.551 - 0.007 0.028
Fat (g) 0.172 0.013 0.273 0.005 - 0.053 0.043 0.083 0.094
Carbohydrates (g) 0.145 0.002 0.221 0.014 - 0.097 0.031 - 0.048 0.031
Sugar (g) 0.204 0.003 0.257 0.003 - 0.037 0.091 - 0.111 0.012
Vitamin A (μg) - 0.242 0.001 - 0.092 0.077 - 0.185 0.014 - 0.016 0.659
Vitamin B1 (mg) - 0.076 0.062 - 0.017 0.121 - 0.171 0.088 0.025 0.595
Vitamin B2 (mg) - 0.092 0.060 - 0.016 0.088 - 0.190 0.053 0.026 0.054
Vitamin B6 (mg) - 0.033 0.238 - 0.005 0.111 - 0.091 0.558 0.060 0.611
Vitamin B12 (μg) 0.027 0.804 0.103 0.584 - 0.017 0.622 0.066 0.595
Folic acid (mg) - 0.028 0.074 0.043 0.036 - 0.150 0.160 0.065 0.730
β-Carotene (μg) - 0.154 0.091 - 0.084 0.145 - 0.175 0.033 0.107 0.428
Vitamin C (mg) - 0.194 0.002 - 0.050 0.051 - 0.172 0.026 0.084 0.083
Vitamin D (μg) - 0.198 0.016 - 0.146 0.033 - 0.217 0.079 - 0.052 0.069
Salt (g) 0.261 0.001 0.321 <0.001 0.051 0.001 0.070 0.028
NNS Non-Nutritive Sweeteneres
The correlations have been calculated with Spearmans’ rho, and the p-values with ordinal logistic fractional polynomial regression adjusted for gender, age
and BMI
Fig. 2 Associations between the intake of NNS in carbonated beverages and intake of nutrients and salt. NNS: Non-Nutritive Sweeteners. The box-and-
whisper plots indicate no (0 unit) /low (0.1 – 2.0 units) / medium (2.1 – 9.0 units) / high (9.0 – 40.0 units) intake of non-nutritive sweeteners in carbonated
beverages. One unit = 100 ml NNS-beverage/day. The correlations have been calculated with Spearmans’ rho, and the p-values with ordinal
logistic fractional polynomial regression.
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active. These aspects have not been focused on in litera-
ture as far as we know. Caffeine- and NNS-containing
beverages might have been used to counteract fatigue
and as an excuse for less physical activity. Diarrhea asso-
ciated with NNS for use in coffee and tea might have
been an adverse event related to some of the NNS.
The association between the use of NNS and BMI is
not clear [8, 26]. The lack of associations between the
use of NNS and BMI in this study was likely because all
subjects were morbidly obese, but could indicate a lack
of weight-reducing effect of NNS. In population-based
observational studies, the use of NNS is higher in over-
weight and obese subjects than in healthy-weight sub-
jects [18–20]. The findings could indicate that NNS
induce weight gain, but it more likely reflects the use of
NNS for weight reduction by overweight and obese
subjects.
Numerous studies from agriculture, in the laboratory
and in humans indicate a counterintuitive effect of NNS
with increased food intake and body weight, accumulation
of fat, weaker caloric compensation, metabolic syndrome
and cardiovascular diseases [27–29]. Animal studies have
shown weight gain and metabolic dysregulation after in-
take of NNS [29, 30]. NNS are not inert substances, and
physiological effects on metabolism and energy balance
have been proposed to explain an unexpected weight-
inducing effect in long-term follow-up studies in children
and adults [7, 31–33]. NNS affect the glucose metabolism
and have been associated with type 2 diabetes [24, 34–36].
Concerns have also been raised about effects on appetite,
eating behaviour, satiation, satiety, craving, reward, addic-
tion, cognitive functions, neurophysiology, and brain func-
tion [22, 23, 37–40].
More recently, the effect of NNS on the gut micro-
biome has achieved considerable attention. The dis-
turbed gut-brain interaction caused by the NNS-induced
dysbiosis might in part explain the effects associated
with obesity such as weight gain, metabolic changes
including glucose intolerance, neurophysiological and
psychological changes [41–43].
Except for a slightly favourable effect in the subgroup
of subjects using NNS-containing non-carbonated bev-
erages, the overall findings were discouraging. It was an-
ticipated that subjects who were referred for obesity and
therefore motivated for weight-reducing interventions,
had a conscious relation to the use of NNS as a way to
reduce energy intake. Most of them had bariatric surgery
later on.
Despite numerous concerns and an extensive litera-
ture, the correct use of NNS is unknown [25]. The ac-
tual knowledge has been summarized by the U.S.
Department of Health and Human Services and U.S.
Department of Agriculture in “Dietary Guidelines for
Americans 2015-2020”: “…. replacing added sugar with
high-intensity sweeteners may reduce calorie intake in
the short-term, yet questions remain about their effective-
ness as a long-term weight management strategy”, and
“Based on available scientific evidence, these high-
intensity sweeteners have been determined to be safe for
the general population” [44]. Shankar et al. gave an intel-
ligent advice “…for optimal health it is recommended
that only minimal amounts of both sugar and NNS be
consumed” [45].
Strengths and limitations
The focus on an unselected group of consecutive sub-
jects with morbid obesity from a general hospital and
their health and lifestyle, and not on overweight and
obesity in general and body weight only, was a strength.
This study from a general hospital is likely to be repre-
sentative of unselected consecutive subjects referred to a
specialized unit for morbid obesity. The validity of the
results for all subjects with overweight and obesity is
unknown. The lack of information about the use of NNS
in other products than beverages and the different types
of NNS was a limitation. The FFQ only asked for the
use of NNS-containing carbonated beverages, non-
carbonated beverages and units of NNS in tea and coffee
and not the specific products. Information about NNS
in packets added to other beverages or food was not
asked for. The limited sample size reduces the ability to
control for confounders. No correction was performed
for the numerous correlations, which increased the risk
of type I errors.
Conclusions
The use of NNS-containing beverages in subjects with
morbid obesity was associated with an unhealthy life-
style, reduced physical and mental health, and unfavour-
able dietary habits. Lifestyle and dietary advice are
therefore particularly important to subjects with morbid
obesity using NNS-containing beverages. There were no
significant associations between the use of NNS-
containing beverages and BMI. The study gave no sup-
port for the recommendation of NNS-containing bever-
ages to subjects with morbid obesity.
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